| Betty Gunter, LPN | |
|
205 E Ray Fine Blvd Ste 6, Roland, OK 74954-5381 | |
| (918) 503-6235 | |
| (918) 503-6239 |
| Full Name | Betty Gunter |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 205 E Ray Fine Blvd Ste 6, Roland, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669856035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | L030492 (Arkansas) | Secondary |
| 164W00000X | Licensed Practical Nurse | 29631 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Betty Gunter, LPN 4763 E 1095 Rd, Roland, OK 74954-5050 Ph: () - | Betty Gunter, LPN 205 E Ray Fine Blvd Ste 6, Roland, OK 74954-5381 Ph: (918) 503-6235 |
News Archive
Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.
Scientists at The Scripps Research Institute (TSRI) have mapped key elements of a severe immune overreaction—a "cytokine storm"—that can both sicken and kill patients who are infected with certain strains of flu virus.
More than seventy percent of people who contract Hepatitis C will live with the virus that causes it for the rest of their lives and some will develop serious liver disease including cancer. However, 30 to 40 percent of those infected somehow defeat the infection and get rid of the virus with no treatment. In this week's Advanced Online Publication at Nature, Johns Hopkins researchers working as part of an international team report the discovery of the strongest genetic alteration associated with the ability to get rid of the infection.
Scientists are to study a group of proteins that are highly effective at killing bacteria and which could hold the key to developing new types of antibiotics.
GI Dynamics, Inc. today announced findings from a new meta-analysis which describes the increasingly robust efficacy and safety profile of EndoBarrier Therapy, an endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and obesity.
› Verified 9 days ago
Krysta Ballard, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 117 E Ray Fine Blvd, Roland, OK 74954 Phone: 918-427-3344 | |
Natalie Webb, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 117 E Ray Fine Blvd, Roland, OK 74954 Phone: 918-427-3344 | |
Jennifer Leigh Chandler, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 117 E Ray Fine Blvd, Roland, OK 74954 Phone: 918-427-3344 | |
Bethany Spaine Browder, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 117 E Ray Fine Blvd, Roland, OK 74954 Phone: 918-427-3344 | |
Tonya Mills, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 117 E Ray Fine Blvd, Roland, OK 74954 Phone: 918-427-3344 Fax: 918-427-3375 | |
Bobbie Jo Martin, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 117 E Ray Fine Blvd, Roland, OK 74954 Phone: 918-427-6644 |